✦ LIBER ✦

9101 Toxicity report of a phase I/II dose escalation study in inoperable locally advanced non-small cell lung cancer with helical tomotherapy and concurrent chemotherapy

✍ Scribed by Bral, S.; Versmessen, H.; Duchateau, M.; Schallier, D.; Everaert, H.; Storme, G.

Book ID: 122733077
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71814-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toxicity report of a phase 1/2 dose-esca

Toxicity report of a phase 1/2 dose-escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy

✍ Samuel Bral; Michaël Duchateau; Harijati Versmessen; Douwe Verdries; Benedikt En 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

Concurrent chemoradiotherapy with tomoth

Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen

✍ Alessandra Bearz,Emilio Minatel,Imad Abu Rumeileh,Eugenio Borsatti… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 243 KB

Phase II study. Concurrent chemotherapy

Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer

✍ Arrieta, Oscar; Blake, Mónika; de la Mata-Moya, María Dolores; Corona, Francisco 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 500 KB

Vinorelbine plus daily low-dose cisplati

Vinorelbine plus daily low-dose cisplatin with concurrent radiotherapy for the treatment of locally advanced inoperable non-small cell lung cancer: A phase I/II study

✍ Pless, M; Kann, R; Biedermann, B; Landmann, C; Herrmann, R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Phase I/II study of weekly docetaxel dos

Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer

✍ Nobuyuki Yamamoto; Yasumasa Nishimura; Kazuhiko Nakagawa; Kaoru Matsui; Masahiro 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 258 KB

Phase I/II study of escalating doses of

Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer

✍ Fumihiro Oshita; Kouzo Yamada; Yuji Kato; Mizuki Ikehara; Kazumasa Noda; Gaku Ta 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 154 KB